139 related articles for article (PubMed ID: 34508270)
1. Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer.
Han XL; Yi CL; Ma JD; He Y; Wu LM; Wang YF; Yang HJ; Liang DY; Shi JF
Lab Med; 2022 Jan; 53(1):71-77. PubMed ID: 34508270
[TBL] [Abstract][Full Text] [Related]
2. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.
Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F
BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551
[TBL] [Abstract][Full Text] [Related]
3. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
4. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
Huang YK; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB; Yan C
PLoS One; 2015; 10(11):e0142080. PubMed ID: 26556485
[TBL] [Abstract][Full Text] [Related]
5. The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China.
Shen H; Xiong K; Wu X; Cheng S; Lou Q; Jin H; Zhang X
Gastroenterol Res Pract; 2021; 2021():6894248. PubMed ID: 33936196
[TBL] [Abstract][Full Text] [Related]
6. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.
Yu G; Wang GX; Wang HG; Mo FF; Tang BB
Neoplasma; 2019 Jul; 66(4):637-640. PubMed ID: 31058531
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
[TBL] [Abstract][Full Text] [Related]
9. The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research.
Tong Y; Wu Y; Song Z; Yu Y; Yu X
BMC Gastroenterol; 2017 Jul; 17(1):88. PubMed ID: 28728545
[TBL] [Abstract][Full Text] [Related]
10. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study.
Tong Y; Wang H; Zhao Y; He X; Xu H; Li H; Shuai P; Gong L; Wu H; Xu H; Luo Y; Wang D; Liu S; Song Z
Front Oncol; 2021; 11():652574. PubMed ID: 34504781
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
13. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
14. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
15. Serum pepsinogen: A potential non-invasive screening method for moderate and severe atrophic gastritis among an asian population.
Nguyen CL; Dao TT; Phi TN; Nguyen TP; Pham VT; Vu TK
Ann Med Surg (Lond); 2022 Jun; 78():103844. PubMed ID: 35734694
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen.
Wu KC; Li HT; Qiao TD; Li CN; Ji WS; Tian FQ; Wang X; Wang BL; Miao JY; Ding J; Fan DM
Chin J Dig Dis; 2004; 5(1):22-7. PubMed ID: 15612668
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of MRI-DWI signal intensity value combined with serum PGI, PGII and CA199 in early gastric cancer.
Li M; Zheng G; Yu L; Tan LL; Li X; Li MJ; Li C; Li S; Liang J; Zhong Z; Li ZM
Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):95-100. PubMed ID: 34817333
[TBL] [Abstract][Full Text] [Related]
19. [The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer].
Lin HZ; Chen L; Li XC; Zhou DF; Cui JY
Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1505-8. PubMed ID: 15733483
[TBL] [Abstract][Full Text] [Related]
20. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
